5.7 C
New York
Saturday, December 9, 2023

Investors’ Patience Is Being Tested Right Now By Ardelyx Inc (NASDAQ: ARDX)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Ardelyx Inc (ARDX) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.11, or 2.54%, to $4.44. The Ardelyx Inc has recorded 64,241 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted XPHOZAH® (tenapanor) Granted Orphan Drug Designation by U.S. FDA for the Treatment of Pediatric Hyperphosphatemia.

Elon Musk just Triggered a BOOM in These Stocks

Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"

Click Here to Download the FREE Report.


Stocks Info

Ardelyx Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $4.33 and fluctuated between $4.4500 as its day high and $4.0100 as its day low. The current market capitalization of Ardelyx Inc is $1.01B. A total of 7.33 million shares were traded on the day, compared to an average of 6.80M shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, ARDX has seen 0 BUY and 10 SELL insider trades, representing the acquisition of 0 and the disposition of 34,593 shares. Over the last 12 months, there were 15 BUYs and 54 SELLs from insiders. Insiders purchased 888,753 shares during that period but sold 184,249.

In the most recent transaction, Williams Laura A sold 25,000 shares of ARDX for 4.00 per share on Nov 15. After the transaction, the Chief Medical Officer now owns 266,839 company shares. In a previous transaction on Oct 10, Rosenbaum David P. sold 1,644 shares at 4.00 per share. ARDX shares that Chief Development Officer owns now total 365,378.

Among the insiders who sold shares, Rosenbaum David P. disposed of 2,897 shares on Sep 08 at a per-share price of $4.55. This resulted in the Chief Development Officer holding 367,022 shares of ARDX after the transaction. In another insider transaction, RAAB MICHAEL sold 11,419 shares at $3.55 per share on Aug 21. Company shares held by the President & CEO now total 876,236.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for ARDX in the last 3 months, the mean price target is $9.58 with high estimates of $12.00 and low estimates of $6.00. In terms of 52-week highs and lows, ARDX has a high of $5.12 and a low of $1.56.

As of this writing, ARDX has an earnings estimate of -$0.1 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.06 per share and a lower estimate of -$0.14. The company reported an EPS of -$0.08 in the last quarter, which was 27.30% higher than expectations of -$0.11.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ARDX’s latest balance sheet shows that the firm has $116.69M in Cash & Short Term Investments as of fiscal 2021. There were $45.50M in debt and $57.55M in liabilities at the time. Its Book Value Per Share was $0.82, while its Total Shareholder’s Equity was $82.62M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ARDX is Buy with a score of 5.00.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles